ASK REDCHAT ANYTHING ABOUT ADDEX THERAPEUTICS LTD
Addex Therapeutics Ltd (NASDAQ: ADXN)
Listen to this Section
$6.63
-0.0740
(
-1.10% )
0.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| ADX71149 (JNJ-40411813) (mGlu2 PAM)DetailsEpilepsy |
Failed |
| Dipraglurant (mGlu5 NAM)DetailsLevodopa-induced dyskinesia associated with Parkinson’s disease |
Failed |
| Dipraglurant (mGlu5 NAM)DetailsDystonia (Blepharospasm) |
Failed |
Market Data
|
| Open |
$6.63 |
| Previous Close |
$6.70 |
| Volume |
0.0K |
| Market Cap |
$8.10M |
| Day Range |
$6.63 - $7.00 |
| 52 Week Range |
$5.41 - $12.05 |
| Shares Outstanding |
1.27M |
| Change % |
-1.10% |
| Net Change |
▼ -0.0740 |
| Insider Ownership |
N/A |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2020 |
| Country | Switzerland |
Insider Ownership Transactions
Total Amount Purchased:
0.00
| Date |
Type |
Amount Purchased |
Purchaser |
| No records found. |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 6-k |
Form 6-K |
5 |
Dec 10, 2025 |
| 424b5 |
Other |
6 |
Dec 10, 2025 |
| 6-k |
Form 6-K |
5 |
Dec 04, 2025 |
| f-3 |
Other |
23 |
Nov 19, 2025 |
| 6-k |
Form 6-K |
2 |
Oct 29, 2025 |
| 6-k |
Form 6-K |
104 |
Sep 30, 2025 |
| 6-k |
Form 6-K |
2 |
Sep 23, 2025 |
| 6-k |
Form 6-K |
2 |
Jun 30, 2025 |
| 6-k |
Form 6-K |
2 |
Jun 25, 2025 |
| schedule |
Other |
1 |
Jun 23, 2025 |